Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Ozempic (semaglutide) and Mounjaro (tirzepatide) are prescription drugs used to manage type 2 diabetes. They can also help with weight loss. Both drugs are injected once per week. Ozempic and ...

Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

A 5 mg vial of the once-weekly drug has been priced at Rs 4,375, while a 2.5 mg vial will cost Rs 3,500. Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the ...

Photograph: Kind courtesy Towfiqu barbhuiya/Pexels.com The company said it has introduced Mounjaro in a single-dose vial presentation following the marketing authorisation from the CDSCO.